Rekindling Vision: Innovative Strategies for Treating Retinal Degeneration
International Journal of Molecular Sciences · 2025
DOI: 10.3390/ijms26094078 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Irfan Khan und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Ophthalmology and Visual Sciences, The Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Sindh, Pakistan. Hauptthemen laut MEDLINE: Retinal Degeneration. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 267 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Retinal degeneration, characterized by the progressive loss of photoreceptors, retinal pigment epithelium cells, and/or ganglion cells, is a leading cause of vision impairment. These diseases are generally classified as inherited (e.g., retinitis pigmentosa, Stargardt disease) or acquired (e.g., age-related macular degeneration, diabetic retinopathy, glaucoma) ocular disorders that can lead to blindness. Available treatment options focus on managing symptoms or slowing disease progression and do not address the underlying causes of these diseases. However, recent advancements in regenerative medicine offer alternative solutions for repairing or protecting degenerated retinal tissue. Stem and progenitor cell therapies have shown great potential to differentiate into various retinal cell types and can be combined with gene editing, extracellular vesicles and exosomes, and bioactive molecules to modulate degenerative cellular pathways. Additionally, gene therapy and neuroprotective molecules play a crucial role in enhancing the efficacy of regenerative approaches. These innovative strategies hold the potential to halt the progression of retinal degenerative disorders, repair or replace damaged cells, and improve visual function, ultimately leading to a better quality of life for those affected.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Ophthalmology and Visual Sciences, The Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Sindh, Pakistan.
- Centre for Regenerative Medicine and Stem Cells Research, The Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Sindh, Pakistan.
- Department of Biological and Biomedical Sciences, The Aga Khan University, Stadium Road, P.O. Box 3500, Karachi 74800, Sindh, Pakistan.
- Dr. Panjwani Center for Molecular Medicine and Drug Research, International Center for Chemical and Biological Sciences, University of Karachi, Karachi 75270, Sindh, Pakistan.
- Department of Ophthalmology and Visual Sciences, University of Alberta, Edmonton, AB T6G 2R3, Canada.
ORCID-Profile: Irfan Khan, Haroon Tayyab, Karim F Damji
Zitieren
APA
Khan, I., Ramzan, F., Tayyab, H., & Damji, K. F. (2025). Rekindling Vision: Innovative Strategies for Treating Retinal Degeneration. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26094078
Vancouver
Khan I, Ramzan F, Tayyab H, Damji KF. Rekindling Vision: Innovative Strategies for Treating Retinal Degeneration. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26094078
BibTeX
@article{Khan2025,
author = {Khan, Irfan and Ramzan, Faiza and Tayyab, Haroon and Damji, Karim F},
title = {Rekindling Vision: Innovative Strategies for Treating Retinal Degeneration},
journal = {International Journal of Molecular Sciences},
year = {2025},
doi = {10.3390/ijms26094078}
}
EUVIMED